Eton Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 24.3M | 21.3M | 22.5M | 18.9M | 17.3M | 11.6M | 10.3M | 9.1M |
| Cost of Goods Sold | 9.5M | 8.2M | 14.6M | 7.0M | 7.4M | 5.2M | 4.0M | 3.4M |
| Gross Profit | 14.7M | 13.1M | 7.9M | 11.9M | 9.9M | 6.5M | 6.3M | 5.6M |
| R&D Expenses | 1.9M | 1.8M | 1.1M | 3.7M | 1.2M | -871K | 505K | 3.0M |
| Operating Expenses | 12.3M | 10.6M | 9.2M | 13.4M | 10.3M | 5.8M | 5.8M | 8.6M |
| Operating Income | 2.4M | 2.5M | -1.4M | -1.5M | -470K | 629K | 509K | -2.9M |
| Other Income / Gains | -840K | -1.1M | -592K | -1.0M | -1.0M | -1.1M | -8K | -52K |
| Net Income | 1.6M | 1.5M | -1.9M | -2.6M | -1.6M | -598K | 627K | -3.0M |
| EPS (Diluted) | 0.06 | 0.055 | -0.07 | -0.096 | -0.059 | -0.023 | 0.024 | -0.12 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.607 | 0.616 | 0.35 | 0.63 | 0.571 | 0.556 | 0.61 | 0.62 |
| General And Administrative Expenses | 10.4M | 8.9M | 8.1M | 9.7M | 9.2M | 6.7M | 5.3M | 5.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 10.4M | 8.9M | 8.1M | 9.7M | 9.2M | 6.7M | 5.3M | 5.6M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 21.9M | 18.8M | 23.8M | 20.4M | 17.8M | 11.0M | 9.8M | 12.0M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -840K | 1.2M | 1.2M | 1.2M | 1.2M | 1.3M | 8K | 52K |
| Depreciation And Amortization | 1.1M | 1.0M | 1.0M | 1.0M | 1.0M | 355K | 278K | 279K |
| Ebitda | 1.9M | 3.6M | 266K | -316K | 678K | -156K | 787K | -2.7M |
| Ebitdaratio | 0.077 | 0.171 | 0.012 | -0.017 | 0.039 | -0.013 | 0.076 | -0.293 |
| Operating Income Ratio | 0.099 | 0.116 | -0.061 | -0.078 | -0.027 | 0.054 | 0.049 | -0.323 |
| Income Before Tax | 1.6M | 1.4M | -2.0M | -2.5M | -1.5M | -511K | 501K | -3.0M |
| Income Before Tax Ratio | 0.065 | 0.066 | -0.087 | -0.133 | -0.087 | -0.044 | 0.049 | -0.329 |
| Income Tax Expense | 20K | -69K | -28K | 66K | 74K | 87K | -126K | 54K |
| Net Income Ratio | 0.064 | 0.07 | -0.086 | -0.137 | -0.091 | -0.051 | 0.061 | -0.335 |
| Epsdiluted | 0.05 | 0.055 | -0.07 | -0.096 | -0.059 | -0.023 | 0.024 | -0.12 |
| Weighted Average Shs Out | 27.3M | 26.9M | 26.9M | 26.9M | 26.9M | 26.1M | 25.9M | 25.8M |
| Weighted Average Shs Out Dil | 31.5M | 26.9M | 26.9M | 26.9M | 26.9M | 26.1M | 26.6M | 25.8M |